Drug Search Results
More Filters [+]

Oxomemazine

Alternative Names: oxomemazine
Latest Update: 2023-11-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Histamine Antagonist,AChR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Belgium | Brazil | Bulgaria | Egypt | France | Indonesia | Israel | Jordan | Korea | Lebanon | Morocco | Switzerland | Taiwan | Tunisia | United Arab Emirates | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: EMS
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Oxomemazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

OGPGEMS0110

P3

Completed

Other

2013-09-30

Recent News Events